US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

69.79

-0.0140-0.02%

Post-market: 69.790.00000.00%16:10 EDT

Volume:315

Turnover:21.91K

Market Cap:697.95K

PE:- -

High:69.83

Open:69.50

Low:69.38

Close:69.80

52wk High:85.03

52wk Low:55.75

Shares:10.00K

Float Shares:10.00K

Volume Ratio:1.02

T/O Rate:3.15%

Dividend:2.08

Dividend Rate:2.98%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent

GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

GSK paying 40% premium to boost the cancer business it previously unwound

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Dow Jones Top Company Headlines at 3 AM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | University ...

GSK to buy Nuvalent in $10.6bn deal to fast-track lung cancer push

Why GSK May Acquire Nuvalent — Report Points to $9B+ Deal Talks

GlaxoSmithKline in Advanced Talks to Acquire Cancer Drug Developer Nuvalent for Up to $10 Billion

24H | Nuvalent Stock Soars 17% as GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn

Tiger Newspress

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live

GSK Boosts Treasury Stock with Latest Share Buyback Tranche

GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

GSK boosts treasury stock as buyback lifts voting share base

GSK Emerges as Unexpected Winner From American Oncology Conference -- Market Talk

Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC)

GlaxoSmithKline (GSK) Gets a Hold from UBS

SBP GROUP (01177) Rises Over 4% as Bepirovirsen Co-developed with GlaxoSmithKline PLC to Unveil Two Phase III Clinical Data at EASL 2026

Sino Biopharm, GSK Report Pivotal Phase III Success for Hepatitis B Drug Bepirovirsen

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/GSKH/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":69.7885,"timestamp":1789502400000,"preClose":69.8025,"halted":0,"volume":315,"hourTrading":{"tag":"盘后","latestPrice":69.7885,"preClose":69.7885,"latestTime":"16:10 EDT","volume":6,"amount":418.731,"timestamp":1789503007262,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.00020056588231074523,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Post-Mkt","change":-0.014,"latestTime":"09-15 18:41:04 EDT","open":69.5,"high":69.83,"low":69.38,"amount":21910,"amplitude":0.006447,"askPrice":104.74,"askSize":200,"bidPrice":34.92,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":69.8025,"nav":66.979706,"aum":669864.039706,"dividendRate":0.029806,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":69.7885,"preClose":69.7885,"latestTime":"16:10 EDT","volume":6,"amount":418.731,"timestamp":1789503007262,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.024724,"impliedVol":0.3521,"impliedVolPercentile":0.9739},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.024724,"shares":10001,"dividePrice":2.0801,"high":69.83,"amplitude":0.006447,"preClose":69.8025,"low":69.38,"week52Low":55.7526,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":69.7885,"eps":0,"divideRate":0.029806,"volume":315,"delay":0,"ttmEps":0,"open":69.5,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":67.5659,"twentyDayClose":69.8844,"sixtyDayClose":71.9341},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164747521","title":"GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=1164747521","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164747521?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:31","pubTimestamp":1780997497,"startTime":"0","endTime":"0","summary":"The British pharmaceutical giant GlaxoSmithKline PLC has finalized an agreement to acquire the US-based biopharmaceutical company Nuvalent, Inc. for a total of $10.6 billion, aiming to significantly...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","GSK.UK","BK4539","GSKH","BK4588","LU1829250122.USD","BK4139","BK4007","NUVL","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642465642","title":"GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2642465642","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642465642?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:07","pubTimestamp":1780996020,"startTime":"0","endTime":"0","summary":"0906 GMT - The initial market reaction to GSK's $10.6 billion acquisition of cancer specialist Nuvalent points to some trepidation among investors about the size of the deal, AJ Bell's Russ Mould says. Nuvalent is the U.K. drugmaker's biggest acquisition in years and fits with its goal of turning oncology into a key growth engine for the group, Mould says. \"GSK is paying a hefty premium to get the deal over the line and the two big lung cancer products flagged by [GSK CEO Luke] Miels in heralding the takeover still await regulatory approval,\" Mould says. \"In rolling the dice on such a big transaction, he is undoubtedly taking a risk.\" GSK shares fall 3.3%. Nuvalent jumps 38% in U.S. premarket trading. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","GSK.UK","BK4139","BK4007","GSK","BK4532","BK4539","BK4585","BK4588","LU1829250122.USD","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642463396","title":"Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2642463396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642463396?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:39","pubTimestamp":1780994340,"startTime":"0","endTime":"0","summary":"Under a new CEO, GSK makes a big bet on cancer drugs. GSK on Tuesday struck a deal to buy Nuvalent for $10.6 billion.U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.GSK last struck a deal of that size in the 2018 deal to buy Novartis out of its consumer healthcare joint venture that later would become Haleon. Novartis also was the counterparty in the complicated 2014 deal in which GSK swapped its oncology portfolio for the Swiss firm's vaccines business.Though it grew by 43% last year, oncology revenue only accounted for GBP2 billion  of GSK's GBP32.67 billion in revenue.Now, GSK is revving up its oncology business once again in buying the Boston company  for $124 per share in cash, a 40% premium to Monday's close in the first major move since new CEO Luke Miels took over the company.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","NUVL","IE00BJJMRZ35.SGD","NVS","BK4007","BK4588","LU0211331839.USD","IE00BFTCPJ56.SGD","GSK.UK","GSKH","LU1829250122.USD","BK4578","LU0070302665.USD","BK4532","BK4539","IE0009355771.USD","GSK","IE0002141913.USD","BK4139","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642450055","title":"GSK paying 40% premium to boost the cancer business it previously unwound","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450055","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450055?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:54","pubTimestamp":1780991640,"startTime":"0","endTime":"0","summary":"This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1829250122.USD","GSK.UK","BK4588","GSKH","BK4007","BK4585","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642450699","title":"GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450699","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450699?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:37","pubTimestamp":1780990620,"startTime":"0","endTime":"0","summary":"GSK on Tuesday struck a deal to buy Nuvalent for $10.6 billion.U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.GSK last struck a deal of that size in the 2018 deal to buy Novartis out of its consumer healthcare joint venture that later would become Haleon. Novartis also was the counterparty in the complicated 2014 deal in which GSK swapped its oncology portfolio for the Swiss firm's vaccines business.Though it grew by 43% last year, oncology revenue only accounted for GBP2 billion  of GSK's GBP32.67 billion in revenue.Now, GSK is revving up its oncology business once again in buying the Boston company  for $124 per share in cash, a 40% premium to Monday's close in the first major move since new CEO Luke Miels took over the company.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4578","BK4588","NVS","BK4007","LU0320765489.SGD","LU1829250122.USD","IE00B2B36J28.USD","BK4139","IE0002141913.USD","GSKH","NUVL","GSK","BK4585","LU0208291251.USD","LU0070302665.USD","LU0211331839.USD","BK4532","BK4539","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642457899","title":"Dow Jones Top Company Headlines at 3 AM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | University ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2642457899","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642457899?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:00","pubTimestamp":1780988400,"startTime":"0","endTime":"0","summary":"The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are under FDA review for approval this year.University Endowments Are About to Strike It Big on the SpaceX IPO. Some schools have a tenth or more of their endowments in Elon Musk's rocket company.OpenAI Files to Go Public in Test of Investor Appetite for Top AI Startups. The ChatGPT maker confidentially filed for an offering, but said 'it may be a while' before it goes public. U.S. Expands List of Chinese Tech Companies It Says Assist Beijing's Military. Some well-known companies were added to the annually updated list, which designates them as a U.S. national-security risk.Meta Launches 'Workforce Academy' to Train Workers to Build Data Centers. The five-week program, which is free of charge and guarantees a job, follows a recent layoff of 8,000 employees.Blackstone-Backed Data-Center Operator Taps Investors Ahead of Over $1.0 Billion Singapore IPO. AirTrunk, founded by Australian billi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YMAG","BK4144","ET","BK4585","BK4581","MAGY","GSKH","IE00BMQBXF63.USD","IE00BZ18W340.USD","BK4139","BK4532","GSK","AM","LU1829250122.USD","BK4590","BK4007","NUVL","GSK.UK","BK4561","BK4588","BK4539","IE00BZ18W456.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642477452","title":"GSK to buy Nuvalent in $10.6bn deal to fast-track lung cancer push","url":"https://stock-news.laohu8.com/highlight/detail?id=2642477452","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642477452?lang=en_us&edition=fundamental","pubTime":"2026-06-09 14:30","pubTimestamp":1780986611,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has agreed to acquire Boston-based clinical-stage oncology specialist Nuvalent for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-to-buy-nuvalent-in-10-6bn-deal-to-fast-track-lung-cancer-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-to-buy-nuvalent-in-10-6bn-deal-to-fast-track-lung-cancer-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU1829250122.USD","NUVL","GSK.UK","GSKH","BK4532","BK4588","BK4585","BK4539","GSK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642439454","title":"Why GSK May Acquire Nuvalent — Report Points to $9B+ Deal Talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2642439454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642439454?lang=en_us&edition=fundamental","pubTime":"2026-06-09 13:58","pubTimestamp":1780984695,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) is reportedly in talks to acquire cancer drugmaker Nuvalent ($NUVL). According to The Financial Times, citing people familia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-gsk-may-acquire-nuvalent-report-points-to-9b-deal-talks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-gsk-may-acquire-nuvalent-report-points-to-9b-deal-talks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSK","BK4539","NUVL","PCOM","LU1829250122.USD","GSK.UK","BK4139","BK4588","GSKH","BK4585","BK4122","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152613863","title":"GlaxoSmithKline in Advanced Talks to Acquire Cancer Drug Developer Nuvalent for Up to $10 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1152613863","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152613863?lang=en_us&edition=fundamental","pubTime":"2026-06-09 11:34","pubTimestamp":1780976086,"startTime":"0","endTime":"0","summary":"Reports indicate that GlaxoSmithKline PLC (GSK.US) is in advanced discussions to acquire cancer therapy company Nuvalent, Inc. (NUVL.US), with the deal valued between $9 billion and $10...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","GSK.UK","BK4139","BK4532","BK4007","NUVL","GSK","GSKH","BK4588","BK4585","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642262458","title":"24H | Nuvalent Stock Soars 17% as GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn","url":"https://stock-news.laohu8.com/highlight/detail?id=2642262458","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642262458?lang=en_us&edition=fundamental","pubTime":"2026-06-09 09:17","pubTimestamp":1780967831,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42G141:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","LU2646069778.SGD","LU0225283273.USD","SG9999013999.USD","LU0289739699.SGD","LU1098665638.USD","LU0306806265.USD","LU1487256676.USD","LU0109981661.USD","LU1064927863.SGD","LU0306807586.USD","LU0987226296.USD","LU1302929846.USD","LU1309081286.SGD","IE00BWDBJ516.SGD","LU1400636657.SGD","SG9999001176.USD","LU1228905540.USD","LU0211331839.USD","LU0545562505.USD","GSKH","LU0058720904.USD","LU1046248800.SGD","LU1481599808.USD","LU1645745479.HKD","LU0225284248.USD","LU0971552830.HKD","IE00B3T34201.USD","LU0985481810.HKD","BK5011","LU1670756490.USD","IE00BQJZX424.USD","LU0321505439.SGD","LU0971552673.USD","IE0034235071.USD","LU1202635105.USD","LU1015430645.USD","BK4539","LU2089984988.USD","GSK","LU0203345920.USD","LU0161305163.EUR","LU1481600234.SGD","LU1983299246.USD","LU1400636574.HKD","BK4139","LU0225771236.USD","SG9999001176.SGD","LU1228905037.USD","SGXZ57979304.SGD","LU0557290698.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641438597","title":"European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2641438597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641438597?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:10","pubTimestamp":1780931424,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biotech firm Evaxion , which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago  and telecommunications company Nokia , which increased 4.4% and 1.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biopharmaceutical company Cellectis , which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi  and biopharmaceutical company Grifols , which were down 2% each.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals  and NuCana , which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP  and biopharmaceutical company Amarin , which ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU0300736492.USD","BK4588","LU0300736062.USD","LU1093756325.SGD","SNY","IE00BMPRXN33.USD","NCNA","BK4208","IE00BMPRXR70.SGD","GSKH","NGG","BP","NOK","TRVG","BK4141","BDRX","BK4599","IE00BKVL7J92.USD","CLLS","LU1162221912.USD","LNOK","EVAX","BK4547","BK4007","NVO","AMRN","BK4077","LU0154236417.USD","LU0006061336.USD","BPH","BK4201","LU1093756168.USD","NVOH","IE00BZ1G4Q59.USD","AUTL","BK4505","GSK.UK","MREO","NVOX","BK4139","GSK","LU0162691827.USD","GRFS","LU0072461881.USD","SQNS","LU0320765646.SGD","LU1829250122.USD","BK4585","IE00BFXG1179.USD","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641480300","title":"GSK Boosts Treasury Stock with Latest Share Buyback Tranche","url":"https://stock-news.laohu8.com/highlight/detail?id=2641480300","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641480300?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:02","pubTimestamp":1780927345,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has continued its existing share buyback programme, repurchasing more than 1.6 millio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-with-latest-share-buyback-tranche?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-with-latest-share-buyback-tranche?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4588","GSKH","BK4532","GSK","GSK.UK","LU1829250122.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641141238","title":"GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2641141238","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641141238?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:31","pubTimestamp":1780677068,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has completed a Phase 1 trial titled “A Phase 1, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-pneumococcal-shot-reaches-key-milestone-in-midlife-adult-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-pneumococcal-shot-reaches-key-milestone-in-midlife-adult-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","GSKH","BK4585","GSK","LU1829250122.USD","BK4588","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640821661","title":"GlaxoSmithKline (GSK) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2640821661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640821661?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:25","pubTimestamp":1780521915,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on GlaxoSmithKline today and set a price target of £25.00. According to TipRanks, Leucht...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSK","BK4588","BK4532","LU1829250122.USD","GSKH","GSK.UK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950348","title":"GSK boosts treasury stock as buyback lifts voting share base","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640950348?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:16","pubTimestamp":1780323389,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK has continued its share buyback programme, repurchasing just under 1.25 million or...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-lifts-voting-share-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-lifts-voting-share-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","US10Y.BOND","BK4585","US5Y.BOND","LU1829250122.USD","TLT","BK4007","US3Y.BOND","US6M.BOND","TLTW","GSK","US2Y.BOND","US7Y.BOND","US30Y.BOND","GSKH","BK4588","US12M.BOND","BK4532","TMF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640930291","title":"GSK Emerges as Unexpected Winner From American Oncology Conference -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2640930291","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640930291?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:53","pubTimestamp":1780307580,"startTime":"0","endTime":"0","summary":"0953 GMT - U.K. drugmaker GSK came out as an unexpected winner from a big U.S. oncology conference, Jefferies analysts say in a note. Early-stage data for GSK's drug candidate IDRx-42 presented at the American Society of Clinical Oncology's annual meeting showed potential as a first-line treatment for gastrointestinal cancer, Jefferies says. Moreover, updates from rivals on new ovarian-cancer drugs didn't top those of GSK's own candidate Mo-Rez, the analysts say. Competition in the market for drugs to treat ovarian cancer resistant to platinum-based chemotherapy is heating up, they add. GSK's Mo-Rez and NaPi2b--developed by Tubulis, which was recently acquired by Gilead Sciences--might be setting the bar for the disease, while AstraZeneca's Puxi-Sam doesn't look as competitive, according to Jefferies. GSK shares fall 0.3%. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4117","BK4007","BK4107","BK4588","GSK","GSKH","LU1829250122.USD","GSK.UK","BK4532","AFG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639606232","title":"Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639606232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639606232?lang=en_us&edition=fundamental","pubTime":"2026-05-30 17:02","pubTimestamp":1780131770,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC). GlaxoSmithKl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-glaxosmithkline-gbgsk-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-glaxosmithkline-gbgsk-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","XLV","BK4139","BK4588","BK4585","CCCC","BK4007","LU1829250122.USD","LU0029874061.USD","LU0128526141.USD","HCSG","GSKH","BK4532","XBI","GSK","LABU","BK4581","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639693623","title":"GlaxoSmithKline (GSK) Gets a Hold from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2639693623","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639693623?lang=en_us&edition=fundamental","pubTime":"2026-05-29 17:00","pubTimestamp":1780045236,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of p1,940.00. According to TipRanks, Weston is ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU1863844665.USD","BK4532","UBS","GSK.UK","GSKH","LU1829250122.USD","BK4585","BK4007","BK4118","BK4588","LU3187612489.SGD","LU1863844749.USD","IE0034235071.USD","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136878581","title":"SBP GROUP (01177) Rises Over 4% as Bepirovirsen Co-developed with GlaxoSmithKline PLC to Unveil Two Phase III Clinical Data at EASL 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136878581","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136878581?lang=en_us&edition=fundamental","pubTime":"2026-05-29 14:38","pubTimestamp":1780036715,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) rose over 4%, up 3.95% at the time of writing, trading at HK$5 with a turnover of HK$428 million. On May 29, SBP GROUP announced that Bepirovirsen, co-developed by its subsidiary,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BK1515","III","BK4532","BK4588","BK1521","HK0000165453.HKD","VXUS","BK4134","01177","BK4007","IE00BZ08YT58.USD","GSK","IE00BZ08YR35.GBP","BK4585","GSK.UK","GSKH","BK1191","LU1829250122.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639612379","title":"Sino Biopharm, GSK Report Pivotal Phase III Success for Hepatitis B Drug Bepirovirsen","url":"https://stock-news.laohu8.com/highlight/detail?id=2639612379","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639612379?lang=en_us&edition=fundamental","pubTime":"2026-05-29 07:38","pubTimestamp":1780011524,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical ( ($HK:1177) ) has provided an update. Sino Biopharmaceutical said its subsidiary Chia Tai Tianqing and partner GSK have rep...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-gsk-report-pivotal-phase-iii-success-for-hepatitis-b-drug-bepirovirsen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-gsk-report-pivotal-phase-iii-success-for-hepatitis-b-drug-bepirovirsen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4532","BK4007","BK4585","GSKH","III","GSK","BK4134","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}